Sylvain Choquet

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

57h-index12.2kcitations504works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(219), CNS Lymphoma Diagnosis and Treatment(154), Chronic Lymphocytic Leukemia Research(127), Viral-associated cancers and disorders(99), Glioma Diagnosis and Treatment(65)

Publications499 total

18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors
Clinical Cancer Research·2026
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy
Journal of Neurology·2026
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia
Leukemia·2025
Large B-cell lymphoma: The LYSA pragmatic guidelines
European Journal of Cancer·2025Open Access
VRH6 : éruption virale liée au HHV-6 chez des patients autogreffés, avec régression sous antiviral
Annales de Dermatologie et de Vénéréologie - FMC·2025
Subgroup analysis based on prior treatment from the Phase 3 allele study of tabelecleucel for epstein-barr virus-driven post-transplant lymphoproliferative disease
Blood·2025Open Access
First results of the methoglu Trial, a phase 1 Trial from the LOC network evaluating the reduction of the time interval between methotrexate perfusions combined with glucarpidase in relapsed primary CNS lymphomas
Blood·2025Open Access
Glofitamab is superior to non a-CD3xC20 treatments for patients with diffuse large B-cell lymphoma who are refractory or relapse immediately after anti-CD19 CAR T-cell therapy: Final results of the bicar study (LYSA) and indirect comparison with a synthetic control arm from the descart registry.
Blood·2025
Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry
Blood·2025
Results of the primary end-point of the LOC-R01: A randomized phase II Study of lenalidomide and ibrutinib in association with rituximab-methotrexate procarbazine vincristin (R-MPV) as a targeted induction treatment for patients aged 18 to 65 with a newly diagnosed primary central nervous system lymphoma (PCNSL)
Blood·2025
Comparison of axicabtagene ciloleucel to standard regimens as second line treatment for large B cell lymphoma in real life: A lysa study from descar-T and realysa registries
Blood·2025
Comparison of axi-cel versus liso-cel as 2nd line therapy for relapsed/refractory large B-cell lymphoma in real-life: A lysa study from the descar-T registry
Blood·2025Open Access
Impact of the number of bridging therapy lines on outcomes after axi-cel in LBCL: A lysa study from the descar-T registry
Blood·2025Open Access
Phase 2/3 trial of zilovertamab vedotin plus standard of care in relapsed/ refractory diffuse large B-cell lymphoma: Updated analysis of waveline-003
Blood·2025Open Access
CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry
Blood·2025Open Access
Safety and efficacy of CD3xCD20 bispecific antibody for the treatment of primary and secondary central nervous system lymphoma patients: A multicentric retrospective study
Blood·2025Open Access
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: a DESCAR-T Registry and International Collaborative Study
Blood·2025Open Access
Glofitamab for patients with Non–Large B-cell lymphoma refractory or relapsing after anti-CD19 CAR T-cell therapy: Final bicar study (LYSA) results.
Blood·2025Open Access
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry
Blood Advances·2025Open Access
P14.07.B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORK
Neuro-Oncology·2025Open Access
page 1 of 25Next →

Frequent Co-authors

Carole Soussain(22), Khê Hoang‐Xuan(18), Caroline Houillier(17), Véronique Leblond(12), Franck Morschhauser(11), Luc Taillandier(11), Rémy Gressin(10), Roch Houot(10), Olivier Chinot(10), Vincent Delwail(9), Valérie Touitou(9), Emmanuel Gyan(9), Nathalie Cassoux(8), Olivier Casasnovas(7), Hervé Ghesquières(7), Julie Abraham(6), Adrien Chauchet(6), Catherine Thiéblemont(6), Cécile Moluçon‐Chabrot(6), Pierre Soubeyran(6)